William Ringo | Chairman and interim CEO |
David Smith | EVP and CFO |
Helen Collins | EVP and CMO |
Martin Forrest | VP, IR and Corporate Communications |
David Ruch | SVB Leerink |
CJ Zopf | Cowen and Company |
Timur Ivannikov | Raymond James |
Ross Weinreb | Goldman Sachs |
Welcome to the Five Prime Therapeutics Third Quarter 2019 Earnings Call.
As a reminder, this conference call is being recorded.
I'd now like to introduce your host for today's conference, Martin Forrest, Vice President of Investor Relations and Corporate Communications.
You may begin.
Thank you, Jimmy.